Mondet Julie, Hussein Kais, Mossuz Pascal
UF de Pathologie Moléculaire, Département d'Anatomie et Cytologie Pathologiques, CHU Grenoble, 38043 Grenoble Cedex 09, France ; Equipe TheRex Laboratoire TIMC-IMAG-UMR5525 CNRS, Université Grenoble Alpes, France.
Institute of Pathology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
Mediators Inflamm. 2015;2015:670580. doi: 10.1155/2015/670580. Epub 2015 Oct 7.
Cytokines are well known mediators of numerous physiological and pathological processes. They contribute to the regulation of normal hematopoiesis but increasing data suggest that they also have a clinical impact in some hematopoietic malignancies. In particular, there is evidence that cytokines are implicated in the functional symptoms of Philadelphia negative myeloproliferative neoplasms (Ph- MPNs), suggesting that evaluation of circulating levels of cytokines could be of clinical interest for the characterization of patients at the time of diagnosis and for disease prognosis. In this review, we present the current knowledge on alteration of circulating cytokine profiles in MPNs and their role in myelofibrosis pathogenesis. Phenotypic correlation, prognostic value of cytokines, and impact of JAK inhibitors are also discussed.
细胞因子是众多生理和病理过程中众所周知的介质。它们有助于正常造血的调节,但越来越多的数据表明,它们在某些造血系统恶性肿瘤中也具有临床影响。特别是,有证据表明细胞因子与费城阴性骨髓增殖性肿瘤(Ph-MPNs)的功能症状有关,这表明评估循环细胞因子水平可能对诊断时患者的特征描述和疾病预后具有临床意义。在这篇综述中,我们介绍了目前关于MPNs中循环细胞因子谱改变及其在骨髓纤维化发病机制中的作用的知识。还讨论了细胞因子的表型相关性、预后价值以及JAK抑制剂的影响。